nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0333	0.0333	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0332	0.0332	CbGpPWpGaD
Amiodarone—ADRB1—Monoamine GPCRs—DRD4—conduct disorder	0.0308	0.0308	CbGpPWpGaD
Amiodarone—ADRB1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0274	0.0274	CbGpPWpGaD
Amiodarone—CYP1A2—Methylation—COMT—conduct disorder	0.0268	0.0268	CbGpPWpGaD
Amiodarone—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0263	0.0263	CbGpPWpGaD
Amiodarone—ADRB1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0259	0.0259	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—GABRA2—conduct disorder	0.0255	0.0255	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.025	0.025	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0216	0.0216	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0203	0.0203	CbGpPWpGaD
Amiodarone—ADRB1—Monoamine GPCRs—HTR2A—conduct disorder	0.0201	0.0201	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—CGA—conduct disorder	0.0191	0.0191	CbGpPWpGaD
Amiodarone—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0178	0.0178	CbGpPWpGaD
Amiodarone—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Amiodarone—ADRB1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0169	0.0169	CbGpPWpGaD
Amiodarone—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0168	0.0168	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—COMT—conduct disorder	0.016	0.016	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0159	0.0159	CbGpPWpGaD
Amiodarone—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0146	0.0146	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—GABRA2—conduct disorder	0.0143	0.0143	CbGpPWpGaD
Amiodarone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0134	0.0134	CbGpPWpGaD
Amiodarone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—COMT—conduct disorder	0.0123	0.0123	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—MAOA—conduct disorder	0.0122	0.0122	CbGpPWpGaD
Amiodarone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Amiodarone—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0109	0.0109	CbGpPWpGaD
Amiodarone—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—POLR3A—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—POLR3A—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Amiodarone—EBP—Metabolism—CGA—conduct disorder	0.00963	0.00963	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0091	0.0091	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00885	0.00885	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00872	0.00872	CbGpPWpGaD
Amiodarone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00854	0.00854	CbGpPWpGaD
Amiodarone—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00807	0.00807	CbGpPWpGaD
Amiodarone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0074	0.0074	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.00693	0.00693	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—COMT—conduct disorder	0.00687	0.00687	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CGA—conduct disorder	0.00686	0.00686	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—MAOA—conduct disorder	0.00682	0.00682	CbGpPWpGaD
Amiodarone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00661	0.00661	CbGpPWpGaD
Amiodarone—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00632	0.00632	CbGpPWpGaD
Amiodarone—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00628	0.00628	CbGpPWpGaD
Amiodarone—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00624	0.00624	CbGpPWpGaD
Amiodarone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00608	0.00608	CbGpPWpGaD
Amiodarone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00602	0.00602	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00595	0.00595	CbGpPWpGaD
Amiodarone—CYP2A6—Biological oxidations—COMT—conduct disorder	0.0058	0.0058	CbGpPWpGaD
Amiodarone—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00575	0.00575	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00532	0.00532	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00532	0.00532	CbGpPWpGaD
Amiodarone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00515	0.00515	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0051	0.0051	CbGpPWpGaD
Amiodarone—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00471	0.00471	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00469	0.00469	CbGpPWpGaD
Amiodarone—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00457	0.00457	CbGpPWpGaD
Amiodarone—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00454	0.00454	CbGpPWpGaD
Amiodarone—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00451	0.00451	CbGpPWpGaD
Amiodarone—EBP—Metabolism—COMT—conduct disorder	0.00435	0.00435	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00432	0.00432	CbGpPWpGaD
Amiodarone—EBP—Metabolism—MAOA—conduct disorder	0.00431	0.00431	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00429	0.00429	CbGpPWpGaD
Amiodarone—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00426	0.00426	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00418	0.00418	CbGpPWpGaD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00397	0.00397	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00396	0.00396	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00393	0.00393	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.00392	0.00392	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00388	0.00388	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.00388	0.00388	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00367	0.00367	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.00356	0.00356	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00353	0.00353	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00351	0.00351	CbGpPWpGaD
Amiodarone—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00348	0.00348	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00337	0.00337	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00333	0.00333	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00325	0.00325	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00321	0.00321	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.0032	0.0032	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EP300—conduct disorder	0.00315	0.00315	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—COMT—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—MAOA—conduct disorder	0.00307	0.00307	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00301	0.00301	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00275	0.00275	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00265	0.00265	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00262	0.00262	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00259	0.00259	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.00253	0.00253	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CGA—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00234	0.00234	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CGA—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00212	0.00212	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CGA—conduct disorder	0.0021	0.0021	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.0021	0.0021	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Amiodarone—EBP—Metabolism—EP300—conduct disorder	0.00186	0.00186	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CGA—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CGA—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CGA—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CGA—conduct disorder	0.00134	0.00134	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—EP300—conduct disorder	0.00133	0.00133	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CGA—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.0013	0.0013	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CGA—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CGA—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—COMT—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—MAOA—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CGA—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—COMT—conduct disorder	0.000991	0.000991	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—MAOA—conduct disorder	0.000984	0.000984	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CGA—conduct disorder	0.000805	0.000805	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—COMT—conduct disorder	0.000782	0.000782	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—MAOA—conduct disorder	0.000776	0.000776	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.000768	0.000768	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—COMT—conduct disorder	0.000738	0.000738	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MAOA—conduct disorder	0.000733	0.000733	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000711	0.000711	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—COMT—conduct disorder	0.000677	0.000677	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MAOA—conduct disorder	0.000672	0.000672	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000652	0.000652	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—COMT—conduct disorder	0.000604	0.000604	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MAOA—conduct disorder	0.0006	0.0006	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—COMT—conduct disorder	0.00059	0.00059	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MAOA—conduct disorder	0.000586	0.000586	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000582	0.000582	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—COMT—conduct disorder	0.000556	0.000556	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MAOA—conduct disorder	0.000552	0.000552	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—COMT—conduct disorder	0.000551	0.000551	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MAOA—conduct disorder	0.000547	0.000547	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000531	0.000531	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—COMT—conduct disorder	0.000471	0.000471	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MAOA—conduct disorder	0.000468	0.000468	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—conduct disorder	0.000464	0.000464	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000453	0.000453	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—conduct disorder	0.000425	0.000425	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—conduct disorder	0.000407	0.000407	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—COMT—conduct disorder	0.000363	0.000363	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MAOA—conduct disorder	0.000361	0.000361	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—conduct disorder	0.000335	0.000335	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—conduct disorder	0.000317	0.000317	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—conduct disorder	0.00029	0.00029	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—conduct disorder	0.000259	0.000259	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—conduct disorder	0.000253	0.000253	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—conduct disorder	0.000238	0.000238	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—conduct disorder	0.000236	0.000236	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—conduct disorder	0.000202	0.000202	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—conduct disorder	0.000156	0.000156	CbGpPWpGaD
